Abstract Details

Title Effects of a novel practice model on medical team burnout in an academic neurology practice

Topic Practice, Policy, and Ethics

Presentation(s) P5 - Poster Session 5 (5:30 PM-6:30 PM)

Poster/Presentation
Number 4-076

Objective To evaluate the effects of practice transformation on medical team burnout in an academic neurology practice

Background As a specialty, neurology has one of the highest rates of clinician burnout. Burnout results in lost revenue and increased risk of physician turnover and can lead to poor patient care. Factors associated with lower risk of burnout include effective support staff, reduced clerical work and effective use of electronic medical records. Practice transformation is a novel practice model that addresses several of these factors and may have a direct impact on multiple aspects of clinical practice, including burnout. Details of the practice transformation model are submitted in an adjunct abstract.

Design/Methods All staff in an academic neurology practice including medical assistants (MAs), nurses, advanced physician providers (APPs) and physicians completed a standardized questionnaire prior to and then at one, three, six and twelve months after initiating practice transformation.

Results Thirty-four team members completed the questionnaire prior to practice transformation. One year after initiating practice transformation, 80% of individuals initially surveyed completed follow up questionnaires. Employee retention was high during the transition to our new practice model. Burnout remained low throughout the evaluation period with scores varying by <10% for physicians, nurses and MAs. At three and six months, APPs reported an 18% increase in prevalence of burnout that was not present at twelve months. Measurements of job satisfaction and levels of job stress remained stable.

Conclusions In our academic neurology practice, a novel model of clinical practice did not impact medical team burnout, job satisfaction or job-related stress for the twelve months after initiation, despite increased patient visit volumes.Long-term assessments are underway.

Authors/Disclosures
Drew S. Kern, MD, FAAN (University of Colorado) PRESENTER	Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Dr. Kern has received research support from Boston Scientific. The institution of Dr. Kern has received research support from AbbVie Pharmaceticals. Dr. Kern has received research support from Medtronic.
Enrique Alvarez, MD, PhD (University of Colorado)	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Kathy A. Deanda, RN, MSN (University of Colorado Hospital)	No disclosure on file
	No disclosure on file
Peter Smith, PhD (Univ of Kansas Medical Center)	No disclosure on file
Laura Palmer (University of Colorado)	No disclosure on file
Jennifer Simpson, MD (University of Colorado Hospital)	Dr. Simpson has nothing to disclose.
Lauren C. Frey, MD (Lauren C Frey MD)	No disclosure on file

��ɫ��

��ɫ��